A human mucosal melanoma organoid platform for modeling tumor heterogeneity and exploring immunotherapy combination options
Lulu Sun(Ministry of Agriculture and Rural Affairs), Shuyang Sun(Guangxi Medical University), Guizhu Yang(Shanghai Stomatological Hospital), Rui Wang(Sun Yat-sen University), Xindan Kang(Shanghai Jiao Tong University), Chong Wang(First Affiliated Hospital of Jiangxi Medical College), Houyu Ju(Shanghai Jiao Tong University)
Cited by 56
Related Papers
The Proteomics Identifications (PRIDE) database and associated tools: status in 2013
|Nucleic Acids Research|2012|2k
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth
|JAMA|2015|420
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
|Journal of Thoracic Oncology|2021|311
High salt primes a specific activation state of macrophages, M(Na)
|Cell Research|2015|243
Nanomaterials for Cancer Precision Medicine
|Advanced Materials|2018|212